Shopping Cart
- Remove All
Your shopping cart is currently empty
(−)-Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 g | $40 | In Stock | |
| 5 g | $92 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock |
| Description | (−)-Myrtenal ameliorates hyperglycemia by enhancing GLUT2 through Akt in the skeletal muscle and liver of diabetic rats. |
| In vivo | Diabetic rats were administered myrtenal (80 mg/kg bw) for a period of 28 days. Diabetic rats showed an increased the levels of plasma glucose, decreased the levels of plasma insulin, down-regulation of insulin receptor substrate 2 (IRS2), Akt and glucose transporter 2 (GLUT2) in liver and insulin receptor substrate 2 (IRS2), Akt and glucose transporter 4 (GLUT4) protein expression in skeletal muscle[1]. |
| Synonyms | (1R)-(−)-Myrtenal |
| Molecular Weight | 150.22 |
| Formula | C10H14O |
| Cas No. | 18486-69-6 |
| Smiles | CC1(C)[C@@H]2C[C@H]1C(C=O)=CC2 |
| Relative Density. | 0.988 g/mL at 20°C(lit.) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (199.71 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.